28-day mortality
30-day death
72-hour cumulative urine volume
8-fluo-camp binding
abdominal problems
abnormal body composition
abnormal cardiac
abnormal liver
abnormal scn5a mrna splicing
abrogate pathological gene expression
absorption function
acetylcholinesterase inhibitor pyridostigmine
acquired heart failure
actin cytoskeleton pathways
action on camp production
activated neurohormonal systems
activators
active
active treatment
activity
acute anthracycline-induced cardiotoxicity
acute autonomic nervous system modulation
acute care hospital
acute care hospitals
acute decompensated hf
acute heart failure clinical trials
acute pulmonary embolism
acute β-ar stimulation
ad-c
ad-c rats
ad-flk
ad-flk rats
adaptive
adenoviral vector
adherence
adjunctive treatment
administration
administrative databases
administrative health
admission median bnp
admission to discharge
adrenergic receptor blockade
advanced chronic obstructive pulmonary disease
advanced copd
advanced heart failure
advanced heart failure therapy
adverse event rates
aerobic
aerobic capacity
aerobic exercise
aerobic exercise training
aerobic training
af type
af-free probability
afterload burden
age
age-
age-by-lvef
aggressive protocols
aging
aim
air pollution
akt
albumin levels
alcohol
aldactone evaluation study
aldosterone antagonist eplerenone
aldosterone antagonist therapy
alendronate- etidronate-
all-cause
allopurinol rats
alphalisa immunoassays
altered protein kinase
ambulatory heart failure trial
ambulatory icd patients
ambulatory patients
ami mortality rates
amplitude
amyloidotic pattern
an
ang
ang ii infusion mouse
angeli
angiotensin converting enzyme inhibitors intolerance
angiotensin ii infusion
angiotensin receptor antagonist valsartan
angiotensin receptor blockers therapy
animals
annular plane systolic excursion
annular size reduction
ans
ans mice
anterior leaflet opening
anthracycline exposure
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-related congestive heart failure
anthracycline-treated breast cancer
anti-inflammatory effects
antiarrhythmic medication
antitumor activity
aortic blood flow
aortic pressure curve
aortic valve repairs
aortic valve replacement
aortic valve surgery
apical
apical rotation
appendicular lean mass index
arg16
aric hf
aric hf model
arrhythmia substrate
arrhythmia-related costs
arterial compliance
artificial pulse
as
at-risk patients
atheromatous coronary disease
atherosclerosis risk
atherosclerosis risk in communautés
atp demand
atp production
atrial explant-derived c-kit
atrial structure
atropine infusion
augmented cyclic guanosine monophosphate
autonomic nervous system activity
b
b-treated
barriers
barriers to exercise
basal
basal contractility
basal rotations
baseline crf
baseline ecgs
baseline electrocardiogram
baseline glomerular filtration rate
baseline hrqol
baseline serum creatinine
baseline st2
bb therapy
bcl-2 mrna expression
bcl-2 proteins
bcl-2/bax
beagle dogs
beat-to-beat qt
beat-to-beat qt interval
behavioural-change
beneficial effect
benefit
benefits
bet bromodomain-containing protein
bet family bromodomain proteins
bet inhibition
beta-blocker hypo-response
beta-blocker therapy
bhlh transcription factor hand2
binding
bioinformatic
biological
biomarker in heart failure
biomarker-guided clinical
biomarker-guided clinical trial
biomedical reasons
biomedical treatment
black ethnicity
black patients
black race
blacks
blinded core laboratory
block electrical activation
blood pressure control
blood testing
blood work
blood-flow paths
blunted cardiac β-ar responsiveness
blunts beta-adrenergic responses
bmi-matched
body composition
body fat distribution
body mass
body weight
bone morphogenetic protein
bradycardia induced
bradycardic response
branch
brd4)
breast cancer patients
breath-holding
breathing control
bridge to recovery
bridging therapy
bt
budget
burden
c-kit
c-kit+ cell differentiation
c-kit+ cell yield
c-terminally processed forms
c-terminally truncated fragments
c57bl
ca
ca(2+)-pump
ca(2+)-uptake
ca2
calcineurin/nfat signalling
calf muscle
california office of statewide health planning
caloric restriction
camp hydrolytic activity
camp-dependent protein kinase
canadian cardiovascular society guidelines
canadian special access programme
cancer
cancers
candesartan in heart failure
canine
cardiac autonomic balance
cardiac benign tumors
cardiac biology
cardiac c-kit
cardiac centre
cardiac development
cardiac diameters
cardiac explant c-kit
cardiac explant-derived cells
cardiac gene control
cardiac genes
cardiac hypertrophic response
cardiac hypertrophy secondary to pressure-overload
cardiac insulin-resistance
cardiac irs1
cardiac l-type channel activity
cardiac mena deletion
cardiac myocyte-specific mena overexpression
cardiac nurse
cardiac nurses
cardiac pathology
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac procedures
cardiac resynchronization
cardiac risk
cardiac sodium current
cardiac specialty hospital
cardiac surgery
cardiac sympathetic tone
cardiac sympathovagal balance
cardiac tissue
cardiac tissues
cardiac transplant recipients
cardiac transplant survival
cardiac vagal
cardiac vagal tone
cardiologist
cardiology practices
cardiology services
cardiology-cardiovascular surgery consensus
cardiomyocyte-like cells
cardiomyopathic restriction
cardioprotective effect
cardiopulmonary exercise
cardiovascular complications
cardiovascular conditions
cardiovascular failure
cardiovascular health
cardiovascular hospitalization
cardiovascular outcomes
cardiovascular reason
cardiovascular risk factors
cardiovascular surgeons
cardiovascular system
cardispiratory fitness
care management
care management coupled
carotid baroreflex activation therapy
carotid bodies
carotid intima-media
caspase-3 activity
catabolic/anabolic imbalance
catabolism
catalytic
catecholamine infusions
catheter-based percutaneous revascularization
caucasian
cause
cause mortality
cause of systolic hf
cd
cd hf
cd133
cd34
cd34+vegfr2
cell adhesion
cell expansion
centers for medicare
centrimag right ventricular assist device
centrimag rvad
cerebral blood flow
cf devices
cf lvad
change
change in readmissions
change in serum cystatin c
charm programme
chelation choices
chelation regimens
chemical instability
chemotherapy-induced heart failure
chf atrial explants
chf patients intubated
chf predictive model
chf visit
chf-dnx
chf-inv
chf-inv rabbits
childhood malignant disease
chinese herbal medicine
chm
chromatin remodeling
chromatin-dependent signal transduction
chromatin-mediated signal transduction
chronic disease
chronic inflammatory state
chronic insulin exposure
chronic kidney disease epidemiology
chronic stable guideline-directed medical therapy
cim
circulating
circulating cd34
circulating mediator of insulin resistance
circulating nt-probnp
circulating plasma ne
circulatory arrest
circulatory derangement
circumferential shortening
class i recommendations
class ii
class ii heart failure
class iii
clcnka gg genotype
clcnka polymorphism
clcnka snp
clin
clinical benefit
clinical change
clinical composite response
clinical doppler echocardiography
clinical excellence registry
clinical modification codes
clinical prediction rule
clinical trial registries
clinical trials
closure
co correlated
co-activating transcription factor networks
co-morbidity burden
cochrane databases
cochrane effective practice
coefficient
cogeneration
cognitive function
cognitive impairment
collagen density
colon
comanagement
commissioning
community outpatients
compensated hff
competitive
complicating ami
computed tomographic angiography
computing readmissions
conditional gene-targeted hand2 mice
congenital abnormalities
congenital heart lesions
congestive heart failure trial
congestive symptoms
conscious
consenting ambulatory hf
contemporary heart failure
content-driven telehealth system
content-driven telehealth technology
continuous nris
contrast agent
controlled randomized trials
controlled trial investigating outcomes
controlled trial investigating outcomes of exercise training
controlled trial investigation
costs
coupling
cox proportional hazard
cox proportional hazards
cox proportional hazards regression
coût
coût-effective
coût-effectiveness
coût-minimization
cpet guiding exercise rehabilitation
cpg-recommended pharmacological treatment
creatine kinase activity
crf distribution
cronbach
cross-sectional
crt off
crt on
crte
crte-d
crude 28-day case-fatality rate
crude rr
cumulative urine volume
currents
curve
cutoff value
cv death
cv deaths
cxl-1020 converts
cxl-1020) myoctyes
cystatin c level
cytotoxic effect
danish heart failure database
data
deactivation
debilitating chronic disease
debilitating stroke
decline
decongestion
decongestion end point
decoy vegf receptor
decreasing albumin
defects
defibrillator-only therapy
deficit
degradation
delayed rhythm control
deleterious β1ar overstimulation
depressed left ventricular
depresses
depression
depressive symptoms
design
detergent
development patient discharge data
device
device consideration
device therapies
devices
diabetic zsf1 rats
dialysis-dependent patients
diameter stenosis
diastolic indices
diastolic mitral annulus
diastolic mitral flow velocity
diastolic mitral leaflet
diastolic properties
diet
diet group
dietary approaches
dietary sodium restriction
diffuse myocardial changes
direct renin inhibitors
discharged alive
discharged patients
discrimination
disease management
disease management programs in heart failure
disease recapitulates
disease-specific costs
diseased human
disposition
distance
distance covered
distance walked
disturbed intestinal barrier
dithiothreitol
diuretic efficacy
diuretic peptides
diuretic refractory severe-end-stage hf
diuretic resistant volume overload
diuretic response
diuretic therapy
diuretic use
dl
dogs
double mutant
doxorubicin cardiotoxicity
doxorubicin efflux transporter abcc2
doxorubicin-induced heart failure
dp-4
dp-4 inhibitors
driveline infection
driveline injury
drs-stratified hazard ratios
drug abrogated
drug discontinuation
drug dose
drug-free
drug-untreated failing hearts
dsd
dt-insensitive cdp choline
dying
dynamic
dynamic resistance training
dynamique
e
e-cfus
e-elateral
e-emean
e-septal
early diastolic mitral annular velocity
early transmitral blood flow
early transmitral flow
early-onset hf
ec coupling gain
eccentric
echo-doppler studies
echocardiographic assessment
echocardiographic evaluations
echocardiographic evidence
echocardiographic examination
echocardiographic measures
echocardiographic predictors
echocardiographic score
echocardiographic substudy
echocardiographic systolic parameters
ecmo group
ecmo+vad
ecmo+vad group
ed visits
eemean
efficacy
efficiency
ehesus
elastance
elastic n2bus segment
elderly
elderly patients
electric remodeling
electrical activation
electrical stimulation
electrocardiographic device
electromechanical behavior
electronic databases
embryonic gene programs
embryonic kidney
emd prolongation
emo
emotional stress
emphasis-hf study
end point of death
end stage heart failure heart failure
end-diastolic dimension
end-stage congestive heart failure
end-tidal co2
endothelial repair
endothelial-protective effects
energy deficit
energy expenditure
english language
enos-ser
enos-thr
enrollment
epigenetic changes
epigenetic readers
eplerenone in mild patients hospitalization
eplerenone post myocardial infarction heart failure efficacy
er kinase
erasers
erk
erythropoiesis-stimulating agent therapy
eseptal
et
ethically complex situations
etiologic causes
european society of cardiology guidelines
evidence-based care
evidence-based medications
exercise
exercise adherence
exercise performance
exercise time
exercise training
exercise-induced
expenditure
expenditures
explant-derived progenitor cells
extracorporeal membrane oxygenation membrane support
failing fontan
failing heart
failing hearts
failure
families
family
fat
fat loss
fat mass index
fat-free mass index
fatigue
fees
fetal gene program
ff
fiber
figure
financier burden
financier costs
findings
fish lacking nucleolin
fit
fixed ring size
fixed-rate atrial pacing
flow-mediated dilatation diameter
fluid
fluorescence resonance energy transfer-based assays
flutter
follow-up exercise capacity
fonctional electrical stimulation
fonctional ms
food and drug administration
force generated
forkhead box
fpassive-sarcomere length relations
frailty in heart failure
free-breathing pulse sequence
functional abnormalities
functional class nyha ii-iii
functional decline
functional deficits
functional enrichment
furosemide dose
futility
g-protein-coupled receptor kinase-2
gain
gating movement
gdmt-treated nyha functional class iii hf
gem
gender
genes coding
genetic susceptibility
genomic reprogramming events
geometry
global proteomics
glomerular filtration
glucose transporter
gly16
go
go test
grls
grly4
grn27
gross income
gross national income
grs
gtpase rac1 activity
guideline recommendations
guideline-heart failure registry
guideline-mandated usual care
guideline-recommended medications
guidelines
guidelines-heart failure
h
h ii
h-action
habc battery score
habc battery scores
haematopoietique cell transplantation
haemodynamic outcomes
haemodynamic stress
ham-innervated
hand
hand grip strength
hand2 in heart failure
handling
harms
hct chf
hct germline dna
hdl function
hdl particles
hdl-bound malondialdehyde
hdl-induced
hdl-mediated protective effects
hdl-mediated vascular effects
health abc
health behaviors
health care expenditures
health insurance
health outcomes
health per capita
health service planning
health service provision
health status
health system data
health systems
healthcare common procedure codes
healthcare programmes
healthcare utilization
healthy control
heart failure adherence
heart failure admission
heart failure clinic
heart failure cost-effectiveness model
heart failure discharges
heart failure disease management
heart failure hospitalization
heart failure mortality
heart failure nurse practitioner
heart failure nurses
heart failure patients
heart failure risk
heart failure-related hospitalization
heart failure-related mortality
heart failure-related qol
heart muscle cells
heart pathologie
heart t2
heart team
heart-specific
heartmate ii devices
heartmate ii exchange
heartmate ii insertion
heartmate ii lvad
heartware intl
heartware patients
helix-loop-helix
hemodynamic alterations
hemodynamic disorder
hemodynamic perturbations
hemodynamic status
hemodynamically unstable
hepatic function
hf admissions
hf canine electromechanics
hf clinic
hf clinic outpatients
hf complicating ami
hf cpgs
hf epidemiology
hf evolution
hf hospital admissions
hf hospitalisations
hf hospitalization
hf mortality
hf pathogenesis
hf pathophysiology
hf patient plasma
hf progression
hf readmissions
hf registry
hf remodeling
hf resources
hf risk
hf risk model
hf units
hf volume management
hf-action cohort
hf-dnx
hf-induced remodeling
hf-related cachexia
hfef
hff
hff therapy
hfpf
hfrf
hfvt
hg
hhf
high-cost medicare beneficiaries
high-fat diet
high-frequency
high-volume eds
high-volume physicians
hnm
hnm group
hnorm
hospital anxiety
hospital clustering
hospital days
hospital discharge
hospital longitudinal change
hospital mortality
hospital performance
hospital quality improvement
hospital quality of care outcomes
hospital rankings
hospital rates
hospital readmission reduction program
hospital stay
hospital-based programmes
hospitalization for heart failure
hospitalized heart failure
hospitalized hf
hospitalized older adults
hp
hpef
hr dynamics
hr variability/turbulence
hretn
ht chest radiation
hum- retn mice
hum-retn mice
human heart failure
human hf
human monocytes
human myocardial tissue
human resistin
human resistin in heart failure
human retn gene
humanized male mice
humanized mouse
humoral stimuli
hvad devices
hypertension diet
hypertrophied heart
hz
hz-dnx
i
i-meta-iodobenzylguanidine
i-mibg
i-mig cardiac washout
i-mig myocardial washout
i6
icd-hf
icu admission
icu mortality
if inhibitor ivabradine trial
immunoreactive nt-probnp
impact
impaired cardiac energy metabolism
impaired cardiac metabolic gene expression
impaired right ventricular pump
impaired systolic function
implant-derived cells
implantable cardioverter defibrillator-crt
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator therapy
implantable implantable cardioverter-defibrillator shocks
implantal pro-brain natriuretic peptide
implantation eligibility status
implantation status
implante
implanted cardioverter-defibrillator device
implanted left-to-right interatrial shunt
implanted monitoring devices
implanted pluripotent stem cell-derived cardiomyocytes
implantg techniques
implanting
implantion
implantment
in conjunction
in vivo inhibition
in vivo rv length-force
in-trial resource utilization
inactive
inappropriate shock therapy
inappropriate therapy
incident cardiovascular events
incident hf
index admission
index ami
index beat
index ed visit
inducible myocardial ischemia
industrial areas
inesthetized dogs
infarcted animals
infarcted hearts
infarcted left ventricle
infarcted rats
infarction-related refractory right heart failure
inflammation-stimulated resistin
inflammatory abdominal
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
influx
ingenuity pathway
inhibition
inhibitor
inhibitory actions
inhospital mortality
inhospital outcomes
inimpaired lv relaxation
inmuscular testosterone supplementation
inoperable chronic thromboembolic pulmonary hypertension
inotrope-dependent
inpatient admissions
inpatient medical conditions
inpatient records
insertion
insulin action
insulin receptor substrates
insulin-signaling
insulin-stimulated rates
insurance status
intact hearts
interconnected molecular pathways
interleukin receptor family
intermediate frailty
intermediate metabolism
intermuscular fat ratio
internal reliability
international right heart foundation
interventions
interventricular septum biopsies
intestinal morphology
intl
intracellular antiadrenergic therapeutic strategy
intravenous inotropes
intravenous iron
intrinsic left ventricular dysfunction
invasive hemodynamic
ip
iron
iron deficiency
iron-deficient adult patients
irs2 double-knockout
irs2 gene double-knockout
irs2 proteins
ischemic cause
ischemic etiology
isoprenaline infusion
ivabradine group
ivabradine unloads
ivabradine-
ivabradine-tre
japanese heart failure
jehovahs witness
joint effect
kaiser permanente northern california
kansas city cardiomyopathy
kaplan-meier
kcal
kcl-ki treatment
kidney index
kidney index score
kidney injury
kilogram
kir
kv4.3 channel mrnas
kv4.3 mrna
l-dko mice
l-type channel inhibition
l-type channel isoforms
l-type voltage-gated
label-free shotgun proteomics
laboratory characteristics
laboratory report
lancet
late-activated lateral wall
late-onset
leaflet motion
leaflet repair
leaflet resection
lean body mass ratio
lean zsf1
lean zsf1 group
left
left main
left ventricular biopsies
left ventricular ejection
left ventricular mechanics
left ventricular tissue
left-hand grip strength
leg strength
length-force relationship
lf
liberal transfusion protocols
life
life-sustaining treatment
lifesaving drugs
lipid-lowering therapy
lipoprotein functional properties
literature
littermate
liver-specific irs1
load-corrected chronotropic response
logistic regression models
lokomat® system
lokomat® system in heart failure
long-acting insulin products
long-standing persistent af
long-term mortality
long-term survival
long-term ventricular assist device
longitudinal strain
low testosterone
low-dose dopamine
low-dose nesiritide
low-frequency
low-volume ed
low-volume eds
low-volume hospitals
low-volume physicians
lower limbs
lung congestion
lung weight
lv end systolic volume index
lv structure
lvad ai
lvad implantation
lvad insertion
lvad surgery
lying
madit-crte
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated lvas
magnetically levitated rotor
magnetically levitéd left ventricular assist system
main outcome
main outcome measure
maintenance
maladaptive cardiac remodelling
maladaptive molecular
maladaptive remodelling
malfunctioning heartmate
malignancies
malondialdehyde bound
management
mapping
mass
md
mean ejection fraction
mechanical dyssynchrony
mechanical support devices
median
median age
median egfr
median follow-up
median left ventricular ejection fraction
medicaid 30-day readmission
medicaid services
medical hospitalization
medical management
medical outcomes
medical records
medical resource
medical support
medical therapies
medically managed diseases
medicare coverage
medicare fee-for-service beneficiaries
medicare hospital claims
medicare inpatient
mediterranean
mediterranean diet score
medium
men
mesenchymal transition markers
metabolic abnormalities
metabolic changes
metabolic enzymes
metabolic risk factors
metric choice
mice
micrornas in heart failure
mild mr
mini-sentinel program
minnesota living with heart failure
mir-25 expression
mistargeting
mitochondrial damage
mitochondrial oxidative phosphorylation
mitochondrial oxidative stress
mitochondrial proteome changes
mitochondrial ultrastructural changes
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide drugs
mitochondrial-targeted peptide ss31
mitral e/e
mitral stenosis reversed
ml
ml/kg/min
ml/m
ml/m2
mlhf
mll
mlt
model fit
modifiable risk factors
modulate hf-related morbidity
molecular biomarkers
molecular mechanism
morpholino-based knockdown
mortality risk
mouse heart
mouse heart failure
mouse hearts
mouse hf
mouse myocardium
mouse rad
mouse tac model
mouse ventricular myocytes
mri-based models
mrna levels
mt
multicenter
multicenter automatic defibrillator implantation
multihospital study
multimarker-based strategy
multiparametric echocardiographic score
multivariable cox modeling
murine myocardium
murine resistin
muscle strength
muscle strip stiffness
muscle strips
muscle-wasting syndrome
muscular strength
mutant mice
mwt
myocardial delayed imaging
myocardial extracellular matrix accumulation
myocardial glycolysis
myocardial infarction-both
myocardial loss
myocardial pde2
myocardial pde2 expression
myocardial phosphodiesterase-2
myocardial t1 changes
myocardial titin hypophosphorylation
myocyte diameter
myofiber
myofibrillar ca(2+)-stimulated atpase activity
myosin binding protein-c phosphorylation
mécanismes of disease
n-
na+ channel mrna splice
na+ current
nad
national cardiovascular disease registry practice innovation
national medicare
natriuretic peptide system
negative coronary angiography
neonatal rat ventricular cardiomyocytes
neprilysin blocks renin-angiotensin-aldosteron
neprilysin inhibitor prodrug
neurohormonal abnormalities
neurohormonal activation
neurohormonally induced heart disease
neutral endopeptidase inhibitors
new york heart association class iii heart failure
new zealand white rabbits
new-onset
nicorandil ameliorates mitochondrial dysfunction
nights spent
non-aas
non-diabetic patients
non-diastolic abnormalities
non-dnx
non-fatal stroke
non-frail
non-ischemic
non-lbbb
non-urbanized midwestern state
noncardiac
noncardiologist physicians
noncardiovascular diagnoses
noncardiovascular drugs
nonfunctional channels
nonglycosylated
nonmitochondrial protein changes
nonpace
nonpace dnx
nonsurvivors
nontrastuzumab
nord america
nordic walking
nordwest united states
norepinephrine-induced hypertrophic
normal
normal geometry
np assessment
nursing management
nursing-sensitive
nursing-sensitive outcome change
nutrition
nutritional abnormalities
nuts
nyha functional class ranking
o2 consumption rate
obese body mass index
obese men
obese zsf1
odds
off-pump sternal sparing approach
office hours
open chest model
open stent
oral glucocorticoid
oral glucocorticoids
organisation of care taxonomy
outpatient models
outpatient settings
overweight
oxidative stress markers
oxygen consumption
oxygen flow
oxygen pulse
oxygen uptake
pace
pace non-dnx
paced myocardium
paediatric cardiac transplants
paediatric heart failure
paf biosynthetic enzymes
paf-cp
paradigm shift
parasympathe
parasympathetic function
participatory
passage
passages
passive/stiffness
pathological cardiac expression programme
pathological gene induction
pathological heart disease
pathological hypertrophy
pathological remodelling
pathological stress
pathophysiologic mechanisms
pathophysiological origin
pathway alterations
pathways
patient compliance
patient enrollment
patient management interventions
patient preferences
patient safety
patient satisfaction
patients enrolled in heart failure
patients hospitalized
patients in heart failure
pattern generator
pay-for-performance
pb cycle
pde superfamily
pde2 activity
pde2 expression
pde2-mediated effects
pde2-overexpressing cardiomyocytes
peak oxygen
pediatric heart failure
pediatric mechanical cardiac support
pediatrics
penalties
perk activation destabilized scn5a
perk inhibition
permanent periodic breathing
permeability
perturbed mitochondrial function
pevk segment
pf cohort
pf-abb
pf-cp
ph-oxidase subunit rac2
pharmacologic management
pharmacologic studies
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
pharmacological treatment
phenylephrine-induced genes
phosphorylation sites
physical activity
physical exhaustion
physician adherence
physician continuity
physician follow-up
physician specialty
physician volume
physio ring
physiologic processes
physiological proteolysis
physique activity
pigs
pka subunits
pkc-βii-ser
placebo-controlled clinical trial
plasticity
pluripotency marker nanog
point-of-care systems
policy
polytetrafluoroethylene tube
poor myocardial function
population-specific health interventions
porcine model of reversible myocardial ischemia
porcine model of right heart failure
positron emission tomography imaging
post-acute care transfer policy
post-myocardial infarction heart
post-myocardial infarction heart failure
posterior wall thickness
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative mortality
postoperative normalization
postsystolic
pre-crt
pre-pd
pre-pd initiation
prediction rule
predictor
preoperative albumin
preserved
pression gradient
pressure
pressure gradient
pressure-overload-induced hypertrophy
pressure-volume conductance catheter system
principal discharge diagnosis
principal findings
prior stroke score
priorities
proangiogenic effects
process redesign
production
prognostic power
programmed cell death
progressive disease
progressive loss
propensity
propensity score decile
prostate
protective effects
protective peptides
protocol-driven poc
province of alberta
proximal circumflex artery
proximal lad
proximal lcx
proximal left anterior descending
proximal left descending artery
pss
psychometric profile
psychometric testing
psychosocial factors
public health
public reporting
pulmonary arterial hypertension medication
pulmonary artery snared
pulse-wave velocity
pump exchanges
pump failure
pump malfunctions
pump replacement
pump-exchange technique
pure epicatechin
pyridostigmine administration
qrs width
qt
quadriceps force
quality improvement database
quality-of-life score
quarterly inpatient admissions
r-r interval oscillations
rabbits
race
rad q66p
radial artery tonometry
radioenzymatic-
radiological signs
radvad
raf-mek1/2-erk1/2 signalling
raised blood glucose
raloxifene-tre
rapid ventricular pacing
ras-
ras-blocker uptitration
rat
rat metabolic risk
rate-control patients
rate-control treatment
rates
ratio of systolic blood pressure
ratios
rats
rcs
re-activation transcription
readmission metric
readmission metrics
readmission rates
readmissions in heart failure
reasons
receiver operating characteristic curve
recent findings
reciprocal downregulation
reciprocal regulation
recommended therapies registry
recreational athletes
refill compliance
refractory
regulation of feeding
regulator of growth
regulatory
regulatory subunit
relaxation
reliability
religious beliefs
remodeling in heart failure
renal atherosclerotic lesions
renal function end point
renin- angiotensin-aldosterone
repolarization lability
repression
resistance training
respiratory
respiratory gas
responsable diagnosis
response
responsiveness
restrictive red blood cell transfusion
resynchronization reverses remodeling
resynchronization-defibrillation
retention trial
reverse cardiac remodeling
reverse remodeling parameters
reversibility
rhythm
rhythm-
right atrial mass removal
right atrium mass
risk
risk of death
risk predictor
risk reduction
risk-adjusted all-cause mortality
risk-adjusted mortality
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
rose acute heart failure
rotterdam
rte
rural south dakota
rv failure management
réseau
réseau meta-analysis
réseaus
s1pr
s1pr1 cardiac gene therapy
safety
salt
schfi
sci
science
scientific literature
scn5a transcript
sd testosterone
sdqt-to-sdrr ratio
seattle heart failure model-predicted survival
self-care confidence scale
self-care education
self-care maintenance scale
self-care management scale
self-care of heart failure index
self-management counseling
septal defects
septal wall cs
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser83 mutant
ser83 phosphorylation
ser96)
serum resistin
serum sodium levels
services management
severe cad
severe frailty
sex
sex-adjusted risk
sham
sham group
sham-inv
sham-operated
shams
sheet orientation
short-form quality of life
shortness of breath
shotgun lc-ms
shunt implants
signal transduction cascade
signaling pathway changes
signalling
signalling cascades
skeletal muscle abnormalities
skeletal muscle mass
skeletal muscle sarcomere structure
skilled nursing facilities
skinfold thickness
skm biopsies
skm mitochondrial structure
slowed conduction
slowness
smad
small-molecule inhibitors
smoked
smoking
smoking cessation
snp rs10927887
social mandate
social support
social support score
socioeconomic status
sodium-restricted dash
sodium-restricted dietary
soluble guanylate cyclase
soluble st2
southeastern minnesota residents
sphingosine-1-phosphate receptor
spironolactone dose
sprague-dawley rats
srd
srd brachial
sst2 status
sst2/high-dose
sst2/high-dose bb
sst2/low-dose bb
stage i-iii breast cancer
standard cardiac rehabilitation
standard heart failure medicines
standing blood pressure
statitistical significance
ste2
stem cell source
stop hypertension
strain rate
stress
stretch rate
stroke prevention trial
structural heart disease
structure
sts hh
subcellular alterations
subclinical atherosclerosis
suburban hospitals
sudden
sudden cardiac death
sudden cardiac deaths
sudden death
surface ecgs
surgical conditions
surgical indication
surgical method of transverse aortic constriction
surgical revascularization
surgical ring implantation
surgical tactics
surgical treatment
surgically induced myocardial infarction
survival
survival study
survival study in heart failure
sustainability
svr index
swedish national inpatient registry
swedish web-system
swine
swine model
sympathetic control
synchrony
syndrome of right heart failure
systemic/uv
systolic heart failure treatment
systolic human heart failure
systolic left v entricular dysfunction
tac cardiac functional deterioration
tac surgery
tac-
tac-induced heart failure
tac-induced proteomic alterations
tachy-
tachycardia-induced heart failure
tachycardic response
tapse-to-pasp ratio
tapse/pasp
target sodium
taxonomy
technique
techniques regression analysis
technologies
telephone support
temporary centrimag rvad
temps
temps-dependent analysis
temps-dependent covariates
temps-domain
temps-varying seattle heart failure
tempsd up
tension
tertiary referral centre
testosterone group
texas cancer registry-medicare
tgf-β inhibition
tgf-β receptor
tgtetmena
tgtetmena mice
thalassaemia
therapeutic interruption
therapeutic left-to-right interatrial shunting
therapeutic strategy
therapy refractory cardiogenic shock
thickness
thigh muscle
throughput
time domain heart rate variability
time to death
timed up
tissue
tissue doppler imaging
tissuefaxs technology correlated
titin isoforms
titin modification
tm interventions
tobacco
tobacco use
toxicity
training-induced changes
trans
transcatheter aortic valve
transduction
transformed
transforming growth factor beta-dependent yield
transgenic mice
transition
transitions of care
transmitral e-wave
transoesophageal echocardiographic guidance
transplant ineligible patients
transplant morbidity
transplant pool
transplant-ineligible patients
transplantation eligibility status
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treating advanced hf
trial-cardiac resynchronization therapy
trichrome blue
trigger
trigger hemoglobin
trpm7) channel mrna
truncated
truncated na+ channels
tta
tttmena mice
twist
two-vessel disease model
ue
ues
um/va/va-rt
unclear etiology
uncontrolled hypertension
underlying heart disease
unfavorable outcome
unfit
unfit men
unfolded protein
unilateral
unintentional weight
university hospital
unloading
unplanned readmission
urban
urban academic medical center
urgent cardiac transplant
urgent readmission
v
va
va healthcare systems
va-rt
vad group
vagal
validity
vasodilator effects
vasopressin receptor antagonist therapy
vco2 slope
vegetables
vegfr2
vehicle
velocity time
ven
vent circulatory failure
ventricle overload
ventricular action
ventricular assist device implantation
ventricular assist device support
ventricular base
ventricular contractile
ventricular contractile reserve
ventricular dilatation
ventricular ejection
ventricular ejection fraction
ventricular ejection fractions
ventricular ejection time
ventricular end-diastolic dimension
ventricular end-diastolic pressure
ventricular filling
ventricular filling pressure
ventricular fractional area change
ventricular longitudinal systolic strain
ventricular midpapillary
ventricular power index
ventricular pressure overload
ventricular structure
ventricular systolic
ventricular tachycardia storm
ventricular wall stress
ventricular-pulmonary arterial coupling
ventricularly paced
viscoelastic
vitesse
voltage-gated cardiac
waist circumference
walk test distance
walking
walking distance
wasting
wave ratio
weak grip
web-based simulation
weight
weight loss
well-treated
western australian
western society
whites
whole grain intake
wilcoxon
wild-type littermates
willebrand factor
wistar rats
women
womens health initiative
wrf
wt riα
yorkshire swine
young woman
zebrafish
zf1 rats
zung
économique
économique analysis
économique climate
économique evaluations
économique impact
économique models
économique savings
β-adrenergic receptor activation
β-adrenergic receptor stimulation
β-ar drive
β-ar stimulation
β-blocker metoprolol
β-blocker uptitration
β-blocker uptitrations
β-blocker-induced enhancement
β-blockers therapy
